On the recordMay 10, 2023
In 1996 the Clinton administration repealed section 936 of the U.S. Internal Revenue Code, which provided tax incentives for drug manufacturers.
Source
congress.govIn 1996 the Clinton administration repealed section 936 of the U.S. Internal Revenue Code, which provided tax incentives for drug manufacturers.
Palmer highlights the negative impact of repealing tax incentives on Puerto Rico's pharmaceutical industry.
Share & report
More from Gary Palmer
What concerns me right now is that we are not doing anything, to my knowledge, to regulate what is going on in the marijuana industry.
It is the responsibility of this Committee to pursue the truth and report it to the American people.